HISUN(SH:600267) Zheng Quan Zhi Xing·2025-05-22 10:28Summary of Key Points Core Viewpoint - Zhejiang Haizheng Pharmaceutical Co., Ltd. has announced its fourth share repurchase plan, aiming to enhance shareholder value and support employee stock ownership plans, with a total repurchase amount expected between 50 million and 100 million RMB [1][2]. Group 1: Share Repurchase Plan - The repurchase plan was first disclosed on May 13, 2025, and will be implemented from May 12, 2025, to May 11, 2026 [1]. - The total amount allocated for the repurchase is between 50 million RMB and 100 million RMB, with a maximum purchase price set at 13 RMB per share [1][2]. - The company has already repurchased 582,000 shares, which accounts for 0.05% of the total share capital, with a total expenditure of 5,317,259 RMB [1][2]. Group 2: Progress of Share Repurchase - The repurchase has been conducted in accordance with the established plan, with the highest purchase price recorded at 9.18 RMB per share and the lowest at 9.08 RMB per share [2]. - The total amount paid for the repurchased shares, excluding transaction fees, is 5,317,259 RMB [2]. - The company will continue to make repurchase decisions based on market conditions and will fulfill its information disclosure obligations regarding the progress of the repurchase [2].